
Cardiamedic Pharmaceuticals Private Limited
About Cardiamedic Pharmaceuticals Private Limited
Data last updated:
Cardiamedic Pharmaceuticals Private Limited is a private limited company based in Kanpur, Uttar Pradesh, India. It operates in the healthcare services segment of the healthcare sector. It was incorporated on 23 March 2010 and has been in existence for over 16 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U85100UP2010PTC107635. Its GSTIN is 09AAFCP3982J1ZW (Uttar Pradesh).
The company has an authorised share capital of ₹2 Lakh and a paid-up capital of ₹1.78 Lakh. It was formerly known as Pluto Tracom Private Limited. It is led by directors Renu Verma and Ashish Pal.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 590 Maswanpur New Basti Shiv Nagar, Kanpur, Uttar Pradesh, India – 208019.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.94 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹5.04 Cr (net margin 102%) and EBITDA of ₹6.37 Cr (EBITDA margin 129%). Revenue has grown at a compounded annual rate (CAGR) of 145% over three years and 100% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN history
Cardiamedic Pharmaceuticals has one previous CIN (Corporate Identification Number): U52100WB2010PTC144277. The current CIN is U85100UP2010PTC107635, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U85100UP2010PTC107635 | Current |
| U52100WB2010PTC144277 | Previous |
Contact details
Cardiamedic Pharmaceuticals Private Limited's registered office is in Kanpur, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered Address590 Maswanpur New Basti Shiv Nagar, Kanpur, Uttar Pradesh, India – 208019
- IndustryHealthcare, Human Health Activities
To see the full contact details of Cardiamedic Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Cardiamedic Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Cardiamedic Pharmaceuticals Private Limited, buy the company report.
Financials of Cardiamedic Pharmaceuticals Private Limited
FY 2025 filings availableCardiamedic Pharmaceuticals Private Limited reported revenue of ₹4.94 Cr (up 321% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 100% over five years, including 321% growth in the latest year. EBITDA rose 163% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.37 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹5.04 Cr | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 129% | ||||
| Net Profit Margin | 102% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Cardiamedic Pharmaceuticals Private Limited, buy the company report.
Board of directors of Cardiamedic Pharmaceuticals Private Limited
Cardiamedic Pharmaceuticals has 2 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Renu Verma | Director | 16 May 2016 | 10 Years 6 Months | Current |
| Ashish Pal | Director | 23 May 2017 | 9 Years 5 Months | Current |
Auditor
Cardiamedic Pharmaceuticals Private Limited is audited by Dhuwalia & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Dhuwalia & Associates | FY 2017 | 325062E |
Shareholding
The shareholding of Cardiamedic Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Cardiamedic Pharmaceuticals Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Cardiamedic Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Cardiamedic Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Cardiamedic Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAFCP3982J1ZW | Uttar Pradesh | Active | 22 May 2019 |
To see the full GST registrations and return filing status of Cardiamedic Pharmaceuticals Private Limited, buy the company report.
Recent activity
Cardiamedic Pharmaceuticals Private Limited has 8 board changes on record since 2016: 2 appointments and 6 cessations. The latest: Ram Bachan Yadav ceased to be Director on 29 Jan 2020.
Frequently asked questions
Cardiamedic Pharmaceuticals is an active private limited company based in Kanpur, Uttar Pradesh, India. The company works in human health activities, within the healthcare industry. It was incorporated on 23 March 2010 (16+ years old) and is registered under CIN U85100UP2010PTC107635.
Cardiamedic Pharmaceuticals has 2 current directors:
- Renu Verma - Director
- Ashish Pal - Director
The latest financial statements of Cardiamedic Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Cardiamedic Pharmaceuticals is 09AAFCP3982J1ZW, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Cardiamedic Pharmaceuticals is U85100UP2010PTC107635. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Cardiamedic Pharmaceuticals was incorporated on 23 March 2010, making it 16+ years old. It is registered with the Registrar of Companies, Kanpur.
Ram Bachan Yadav ceased to be Director on 29 Jan 2020. Ashish Pal ceased to be Additional Director on 30 Sep 2017. Ashish Pal was appointed as Director on 23 May 2017. Cardiamedic Pharmaceuticals has 8 board changes on record in total.
The registered office of Cardiamedic Pharmaceuticals is at 590 Maswanpur New Basti Shiv Nagar, Kanpur, Uttar Pradesh, India – 208019.
Cardiamedic Pharmaceuticals operates in the healthcare industry, in the human health activities segment.
The compliance status of Cardiamedic Pharmaceuticals is compliant as of 15 July 2026. The company is actively filing with the Registrar of Companies.

